Global Cell Culture? Market: Snapshot
Pharmaceuticals industry is adopting the
cell culture trend at a rapid pace. The removal of living cells from an
animal or a plant and developing these cells in a controlled and
artificial environment is called the process of cell structure. The
market for cell structure is anticipated to draw more revenue with major
players concentrating on research and development in biopharmaceuticals
field.
Major vendors of the cell culture market
are stressing more on expansion of their product and using strategies
that can help in collaborations in order to have a strong foothold in
the entire market. Asia Pacific and Latin America are regions with the
most potential hence, players are developing collaboration programs in
order to establish their market in the aforementioned areas.
The launch of new and advanced system is
expected to boost the global cell culture market in the long run
especially for production on a large-scale basis. The advantages of this
is that it is cost efficient as well as retains a very low
contamination risk. This serves as a great deal to the players of cell
culture market.
However, factors like the high standard
quality set by leaders of the market and solid regulatory framework
imposition may act as a hindrance to the overall growth of the market in
the future years. In addition to that, strict regulations, and fetal
bovine serum that is required for cell culture production are also
envisioned to restrict the market growth. Besides, ethical rules and
regulations proportional to using high expenditure in terms of
infrastructure is also seen as a restraining factor for the future
growth of the market.
Nevertheless, due to the fact that both
developing as well as developed nations are putting more focus on
treating chronic diseases, the cell culture market will soon see a rapid
growth as there is more demand for cost efficient and effective
products in the market.
The global cell culture market was worth a
US$ 13.0 Bn in 2016 and is presumed to expand at a 10.0% CAGR within
the forecast period of 2017 to 2025.
Chemically Defined Mediums Adaptation to Boost Market Growth
Owing to the rising trend approaching the
usage of component-free, and animal-derived mediums and the acceptance
of specialty and chemically defined mediums, the global cell culture
market is yet to witness remarkable growth in the coming years.
The global cell culture market is
classified on the basis of end user and product. As per the
classification of end user, the global cell culture market is divided
into research institutes, academic institutes, pharmaceutical companies,
and biotechnology companies.
On the basis of product, the market is
segmented into reagents, sera, mediums, and instruments. Further
classification of instruments are cryogenic tanks, biosafety cabinets,
carbon dioxide incubators, and cell culture vessels (Bioreactors).
Further segmentation of mediums are specialty mediums, protein-free
mediums, serum-free mediums, lysogeny broths, classical mediums, and
chemically defined mediums. Sera is further categorized into Fetal
Bovine Serum (FBS). Reagents are further segmented into amino acids,
attachment factors, thrombin, protease inhibitors, albumin, and growth
factors & cytokines.
Asia Pacific to Increase Market Revenue with Rise in Outsourcing Activities
The global cell culture market is studied
on the basis of key geographies Latin America, Middle East and Africa,
Europe, Asia Pacific, and North America. Asia Pacific is anticipated to
boost the market in the coming years owing to the rise in manufacturing
of biopharmaceuticals and increase in outsourcing activities over the
region.
Major players in the cell culture market
are Merck KGaA, Lonza, Thermo Fisher Scientific Inc., Dickinson and
Company, VWR International LLC, and Sartorius AG.
No comments:
Post a Comment